|Videos|May 17, 2021
Deep Dive: Deep Dive Into Huntington's Disease
Dr. Daniel Claassen, a Huntington's disease specialist and the head of Vanderbilt’s HD Center of Excellence, joins Deep Dive.
Dr. Daniel Claassen, a Huntington's disease specialist and the head of Vanderbilt’s HD Center of Excellence, joins Deep Dive to discuss the recent news that Roche and Wave Life Sciences were discontinuing the development of their respective HD treatments, May what promise still remains in the pipeline, and how crucial it is for the HD community to maintain hope in light of these 2 failures.
Related Articles
- Deep Dive: Into Improving Patient Outcomes Through AI
August 16th 2023
- Behind the Science: Behind Chemotherapy Shortages
August 15th 2023
- Deep Dive: Into Types of Chromatography
August 15th 2023
- Deep Dive: Into Clinical Trials & Reproductive Health
August 4th 2023
- Deep Dive: Into Diabetic Retinopathy
August 3rd 2023
- Deep Dive: Into AHN’s Fertility Clinic
August 2nd 2023